INmune Bio Inc.

Historical 13F Holders

Symbol
INMB
CUSIP
45782T105
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 45782T105 since 12/18/2024, largest first.

Filer % of Class Filed
Highbridge Capital Management, LLC 13G/A 5.2% 8/14/2025
Event 6/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
CVI Investments, Inc. 13G/A
4.9% 8/14/2025
Event 6/30/2025
Praetorian PR LLC 13G/A
3.4% 8/14/2025
Event 6/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 21.6 k $42.1 k
2026 Q2 85 4.34 M $7.08 M
2026 Q1 87 5.38 M $6.09 M
2025 Q4 78 5.08 M $7.93 M
2025 Q3 82 4.71 M $9.76 M
2025 Q2 99 5.68 M $12.8 M
2025 Q1 90 6.17 M $48.1 M
2024 Q4 78 6.33 M $29.5 M
2024 Q3 72 5.36 M $28.9 M
2024 Q2 64 4.60 M $40.6 M
2024 Q1 58 2.80 M $32.8 M
2023 Q4 56 2.31 M $26.0 M
2023 Q3 44 2.14 M $14.5 M
2023 Q2 41 2.19 M $24.9 M
2023 Q1 38 1.81 M $11.7 M
2022 Q4 40 1.69 M $10.7 M
2022 Q3 37 1.92 M $11.9 M
2022 Q2 39 2.02 M $17.7 M
2022 Q1 38 2.30 M $19.3 M
2021 Q4 48 2.58 M $26.3 M
2021 Q3 50 1.94 M $37.7 M
2021 Q2 44 1.74 M $30.6 M
2021 Q1 35 1.31 M $15.5 M
2020 Q4 28 865 k $15.2 M
2020 Q3 29 993 k $10.3 M
2020 Q2 17 359 k $1.88 M
2020 Q1 15 344 k $1.14 M
2019 Q4 12 283 k $1.64 M
2019 Q3 12 275 k $1.62 M
2019 Q2 8 38.8 k $375 k
2019 Q1 6 45.1 k $352 k